Search Results

Search Results for "depuy"

• Lawyers give arguments in J&J fraud case
  Lawyers representing Pennsylvania and Johnson & Johnson both argued their side before a panel of seven Commonwealth Court justices on Wednesday, in a case involving allegations that Johnson & Johnson defrauded Pennsylvania out of millions of taxpayer dollars. At issue is whether the company ...

• State court hears appeal in J&J fraud case
  Commonwealth Court judges are scheduled to hear an appeal of the decision dismissing Pennsylvania’s 2008 lawsuit against Johnson & Johnson. The company is accused of fraudulently profiting from sales of the antipsychotic drug Risperdal through the Medicaid program. According to an article in t...

• Outgoing J&J CEO pay cut seen as good sign
  An entry on investment blog Seeking Alpha says that Johnson & Johnson is still trying to regain its footing after a disastrous series of recalls. But the blog advises investors that big salary cut for former CEO William Weldon, who has been demoted to chairman, is a good sign. Alex Gorsky, the c...

• Hip implant patients should be checked regularly
  Physicians quoted in an article in Arthritis Today about all-metal hip implants said patients who received the devices should get checked regularly to make sure metal debris known to break off from the devices aren’t causing them any health problems. The implants, featuring both a head and a socke...

• J&J wants to expand marketing for drug
  According to a story in the Washington Post, Johnson & Johnson has applied to the U.S. Food and Drug Administration to get approval of another use for its anti-clotting drug Xarelto. Johnson & Johnson currently markets Xarelto for reducing the risk of blood clots in patients after knee or hi...

• FDA fails to track medical devices
  A piece in the Denver Post faults the U.S. Food and Drug Administration’s minimal monitoring of medical devices, and says the existing system leads to injuries and deaths from faulty devices allowed to remain on the market. According to the article, prescription drugs have unique codes that can be...

• NPR examines $1B Johnson & Johnson fine
  An NPR report on an Arkansas jury’s billion-dollar decision against Johnson & Johnson mentions that the company is most famous for its baby shampoo and wryly notes: “So much for no more tears.” The federal court decision was in response to allegations that the company used misleading marke...

• Feds want to question new J&J CEO in Risperdal fraud case
  In a motion filed as part of a fraud case against Johnson & Johnson, the federal government alleges that new company CEO Alex Gorsky “was actively involved in matters at issue in this case,” Forbes reports. Government prosecutors charge that Johnson & Johnson paid kickbacks to Omnicare, ...

• Top Johnson & Johnson officials try to reassure shareholders
  During Johnson & Johnson’s annual meeting, outgoing CEO Bill Weldon and successor Alex Gorsky both tried to reassure shareholders that the company is getting its act together, the Washington Post reports. According to the Washington Post, shareholders were “upset over the health giant’s ba...

• Article says FDA approval process is flawed
  In a recent article titled “Four Medical Implants that Escaped FDA Scrutiny,” Scientific American takes a critical look at a U.S. Food and Drug Administration approval process that allows dangerous medical devices to be sold in the United States. The article states that the rate of recalls, faul...